Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study

References

• Coccaro EF. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. J Clin Psychiatry 1998; 59(Suppl1)30–5
   PubMedGoogle Scholar
• Hirschfeld RM. Pharmacotherapy of borderline personality disorder. J Clin Psychiatry 1997; 58(Suppl 14)48–52
   PubMed Web of Science ®Google Scholar
• Markovitz PJ, Schulz SC. Drug treatment of personality disorders. Br J Psychiatry 1993; 162: 122
   PubMedGoogle Scholar
• Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Comp Psychiatry 1993; 34(6)402–5
   PubMed Web of Science ®Google Scholar
• Benedetti F, Sforzini L, Colombo C, et al. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998; 59: 103–7
   PubMed Web of Science ®Google Scholar
• Schulz SC, Camlin KL, Berry SA, et al. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999; 46(10)1429–35
   PubMed Web of Science ®Google Scholar
• Zullino DF, Quinche P, Hafliger T, et al. Olanzapine improves social dysfunction in cluster B personality disorder. Hum Psychopharmacol 2002; 17(5)247–51
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001; 62(11)849–54
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004; 65(7)903–7
   PubMed Web of Science ®Google Scholar
• Bogenschutz MP, George NH. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 2004; 65(1)104–9
   PubMed Web of Science ®Google Scholar
• Szigethy EM, Schulz SC. Risperidone in comorbid borderline personality disorder and dysthymia. J Clin Psychopharmacol 1997; 17(4)326–7
   PubMed Web of Science ®Google Scholar
• Khouzam HR, Donnelly NJ. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. J Nerv Ment Dis 1997; 185: 348–9
   PubMed Web of Science ®Google Scholar
• Rocca P, Marchiaro L, Cocuzza E, et al. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 2002; 63(3)241–4
   PubMed Web of Science ®Google Scholar
• Hilger E, Barnas C, Kasper S. Quetiapine in the treatment of borderline personality disorder. World J Biol Psychiatry 2003; 4(1)42–4
   PubMed Web of Science ®Google Scholar
• Walker C, Thomas J, Allen TS. Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine. Int J Offender Ther Comp Criminol 2003; 47(5)556–67
   PubMed Web of Science ®Google Scholar
• Gruettert T, Friege L. Quetiapine in patients with bordeline personality disorder and psychosis: a case series. Int J Psychiatry Clin Pract 2005; 9(3)180–6
   PubMed Web of Science ®Google Scholar
• Villeneuve E, Lemelin S. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target. J Clin Psychiatry 2005; 66(10)1298–303
   PubMed Web of Science ®Google Scholar
• Wistedt B, Rasmussen A, Pedersen L, et al. The development of an observer-scale for measuring social dysfunction and aggression. Pharmacopsychiatry 1990; 23(6)249–52
   PubMed Web of Science ®Google Scholar
• Compendium Suisse des médicaments 2005. Switzerland: Documed. , SA: Bâle; 2005.
   Google Scholar
• Guelfi JD. L'évaluation clinique standardisée en psychiatrie. BoulogneL Editions Médicales Pierre Fabre. 1996
   Google Scholar
• Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987; 334: 81–94
   Google Scholar
• Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia – A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997; 54: 549–57
   PubMed Web of Science ®Google Scholar
• Baumann P, Hiemke C, Ulrich S, et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243–65
   PubMed Web of Science ®Google Scholar
• Hasselstrøm J, Linnet K. Quetiapine serum concentrations in psychiatric patients – The influence of comedication. Ther Drug Monit 2004; 26: 486–91
   PubMed Web of Science ®Google Scholar
• Hartter S, Connemann B, Schonfeldt-Lecuona C, et al. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. J Clin Psychopharmacol 2004; 24(5)568–71
   PubMed Web of Science ®Google Scholar
• Gex-Fabry M, Balant-Gorgia AE, Balant LP. Potential of concentration monitoring data for a short half-life drug: Analysis of pharmacokinetic variability for moclobemide. Ther Drug Monit 1995; 17: 39–46
   PubMed Web of Science ®Google Scholar
• DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine – An atypical antipsychotic. Clin Pharmacokinet 2001; 40(7)509–22
   PubMed Web of Science ®Google Scholar
• Cowdry RW. Psychopharmacology of borderline personality disorder: a review. J Clin Psychiatry 1987; 48(Suppl)15–25
   PubMedGoogle Scholar
• Raj, A. Overview and treatment of social anxiety disorder. Manage Care 2004; 13(6 Suppl Depression):52–7.
   PubMedGoogle Scholar
• Villeneuve E, Lemelin S. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target. J Clin Psychiatry 2005; 66(10)1298–303
   PubMed Web of Science ®Google Scholar
• Basson BR, Kinon BJ, Taylor CC, et al. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 2001; 62(4)231–8
   PubMed Web of Science ®Google Scholar